PGK1 and glioblastoma: In this study, we constructed a biomimetic hypoxia-triggered RNAi nanomedicine (poly(MIs)/PTX@PEI/siPGK1@CCM) for synergistically sensitizing chemotherapy and radiotherapy by inhibiting PGK1-promoted GBM progression.